Exosome mimetics: a novel class of drug delivery systems

被引:432
|
作者
Kooijmans, Sander A. A. [1 ]
Vader, Pieter [1 ]
van Dommelen, Susan M. [1 ]
van Solinge, Wouter W. [1 ]
Schiffelers, Raymond M. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
来源
基金
欧洲研究理事会;
关键词
exosomes; extracellular vesicles; liposomes; drug delivery systems; CELL-DERIVED EXOSOMES; DENDRITIC CELLS; PROTEOMIC ANALYSIS; MEMBRANE-VESICLES; TETRASPANINS CD9; FREE EXPRESSION; STEM-CELLS; IN-VIVO; CIRCULATING MICRORNAS; APOPTOTIC BODIES;
D O I
10.2147/IJN.S29661
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The identification of extracellular phospholipid vesicles as conveyors of cellular information has created excitement in the field of drug delivery. Biological therapeutics, including short interfering RNA and recombinant proteins, are prone to degradation, have limited ability to cross biological membranes, and may elicit immune responses. Therefore, delivery systems for such drugs are under intensive investigation. Exploiting extracellular vesicles as carriers for biological therapeutics is a promising strategy to overcome these issues and to achieve efficient delivery to the cytosol of target cells. Exosomes are a well studied class of extracellular vesicles known to carry proteins and nucleic acids, making them especially suitable for such strategies. However, the considerable complexity and the related high chance of off-target effects of these carriers are major barriers for translation to the clinic. Given that it is well possible that not all components of exosomes are required for their proper functioning, an alternative strategy would be to mimic these vesicles synthetically. By assembly of liposomes harboring only crucial components of natural exosomes, functional exosome mimetics may be created. The low complexity and use of well characterized components strongly increase the pharmaceutical acceptability of such systems. However, exosomal components that would be required for the assembly of functional exosome mimetics remain to be identified. This review provides insights into the composition and functional properties of exosomes, and focuses on components which could be used to enhance the drug delivery properties of exosome mimetics.
引用
收藏
页码:1525 / 1541
页数:17
相关论文
共 50 条
  • [1] Drug loading techniques for exosome-based drug delivery systems
    Xi, Xiao-Ming
    Chen, Meng
    Xia, Shu-Jun
    Lu, Rong
    PHARMAZIE, 2021, 76 (2-3): : 61 - 67
  • [2] Exosome-based drug delivery systems in cancer therapy
    Tianqi Wang
    Yanan Fu
    Shengjie Sun
    Chenyi Huang
    Yunfei Yi
    Junqing Wang
    Yang Deng
    Meiying Wu
    ChineseChemicalLetters, 2023, 34 (02) : 121 - 128
  • [3] Exosome-based drug delivery systems and their therapeutic applications
    Lee, Jaewook
    Lee, Ji-Heon
    Chakraborty, Kushal
    Hwang, Joon
    Lee, Yong-Kyu
    RSC ADVANCES, 2022, 12 (29) : 18475 - 18492
  • [4] Exosome-based drug delivery systems in cancer therapy
    Wang, Tianqi
    Fu, Yanan
    Sun, Shengjie
    Huang, Chenyi
    Yi, Yunfei
    Wang, Junqing
    Deng, Yang
    Wu, Meiying
    CHINESE CHEMICAL LETTERS, 2023, 34 (02)
  • [5] Geographic variation in uptake of a novel drug class: the case of incretin mimetics
    Marcum, Z. A.
    Driessen, J.
    Thorpe, C.
    Donohue, J.
    Gellad, W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 : S132 - S132
  • [6] Novel drug delivery systems
    Leland Lou
    Current Review of Pain, 1999, 3 (5): : 411 - 416
  • [7] NOVEL DRUG DELIVERY SYSTEMS
    VANBRUNT, J
    BIO-TECHNOLOGY, 1989, 7 (02): : 127 - 130
  • [8] NOVEL DRUG DELIVERY SYSTEMS
    LANGER, R
    CHEMISTRY IN BRITAIN, 1990, 26 (03) : 232 - &
  • [9] Exosome-based drug delivery systems for enhanced neurological therapeutics
    Vahab, Safa A.
    Vyshma, K. V.
    Kumar, Vrinda S.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2025, 15 (04) : 1121 - 1138
  • [10] Challenges in the development and establishment of exosome-based drug delivery systems
    Wang, Jin
    Chen, Derek
    Ho, Emmanuel A.
    JOURNAL OF CONTROLLED RELEASE, 2021, 329 : 894 - 906